These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 27763866)

  • 21. Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial.
    Chaker AM; Shamji MH; Dumitru FA; Calderon MA; Scadding GW; Makatsori M; Jones I; He QA; Subramanian KK; Arm JP; Durham SR; Schmidt-Weber CB
    J Allergy Clin Immunol; 2016 Feb; 137(2):452-461.e9. PubMed ID: 26531865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antigen specific immunoglobulin E to grass and weed pollens in the plasma of patients with seasonal allergic rhinitis].
    Silny W; Kuchta D; Siatecka D; Silny P
    Otolaryngol Pol; 1999; 53(1):55-8. PubMed ID: 10337158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgE cross-reactivity between meadow fescue pollen and kiwi fruit in patients' sera with sensitivity to both extracts.
    Gavrović-Jankulović M; Cirković T; Burazer L; Vucković O; Jankov RM
    J Investig Allergol Clin Immunol; 2002; 12(4):279-86. PubMed ID: 12926188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Grass pollen immunotherapy: where are we now.
    Würtzen PA; Gupta S; Brand S; Andersen PS
    Immunotherapy; 2016; 8(4):399-411. PubMed ID: 26973122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
    Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and tolerability of grass pollen tablets in sublingual immunotherapy--a phase-1 study.
    Larsen TH; Poulsen LK; Melac M; Combebias A; Andre C; Malling HJ
    Allergy; 2006 Oct; 61(10):1173-6. PubMed ID: 16942564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of IgG antibodies to house dust mite and grass pollen by a solid-phase radioimmunoassay.
    Delespesse G; Debisschop MJ; Flament J
    Clin Allergy; 1979 Sep; 9(5):503-14. PubMed ID: 91453
    [No Abstract]   [Full Text] [Related]  

  • 28. High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study.
    Wahn U; Klimek L; Ploszczuk A; Adelt T; Sandner B; Trebas-Pietras E; Eberle P; Bufe A;
    J Allergy Clin Immunol; 2012 Oct; 130(4):886-93.e5. PubMed ID: 22939758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular profile clustering of IgE responses and potential implications for specific immunotherapy.
    Matricardi PM
    Curr Opin Allergy Clin Immunol; 2013 Aug; 13(4):438-45. PubMed ID: 23799338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody profiles and self-reported symptoms to pollen-related food allergens in grass pollen-allergic patients from northern Europe.
    Ghunaim N; Grönlund H; Kronqvist M; Grönneberg R; Söderström L; Ahlstedt S; van Hage-Hamsten M
    Allergy; 2005 Feb; 60(2):185-91. PubMed ID: 15647039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical results from vaccination with recombinant grass pollen allergens.
    Jutel M; Cromwell O
    Clin Dev Immunol; 2006; 13(2-4):389-94. PubMed ID: 17162383
    [No Abstract]   [Full Text] [Related]  

  • 32. Profilin cross-reactive panallergen causes latex sensitization in the pediatric population allergic to pollen.
    Casquete-Román E; Rosado-Gil T; Postigo I; Guisantes JA; Fernández M; Torres HE; Martínez-Quesada J
    Ann Allergy Asthma Immunol; 2012 Sep; 109(3):215-9. PubMed ID: 22920078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and treatment of grass pollen-induced allergic rhinitis in specialized current clinical practice in Spain.
    Valero A; Chivato T; Justicia JL; Navarro AM;
    Allergy Asthma Proc; 2011; 32(5):384-9. PubMed ID: 22195692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost effectiveness analysis of immunotherapy in patients with grass pollen allergic rhinoconjunctivitis in Germany.
    Westerhout KY; Verheggen BG; Schreder CH; Augustin M
    J Med Econ; 2012; 15(5):906-17. PubMed ID: 22533527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modifications in IgG subclasses in the course of immunotherapy with grass pollen.
    García BE; Sanz ML; Diéguez I; de las Marinas MD; Oehling A
    J Investig Allergol Clin Immunol; 1993; 3(1):19-25. PubMed ID: 8281327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy.
    Van Overtvelt L; Baron-Bodo V; Horiot S; Moussu H; Ricarte C; Horak F; Zieglmayer P; Zieglmayer R; Montagut A; Galvain S; de Beaumont O; Le Gall M; Moingeon P
    Allergy; 2011 Dec; 66(12):1530-7. PubMed ID: 21883279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing long-term safety of seasonal grass pollen sublingual immunotherapy: the ECRIT study.
    Sieber J; Neis M; Brehler R; Fölster-Holst R; Kapp A; Klimek L; Merk H
    Expert Opin Drug Saf; 2012 Jan; 11(1):7-13. PubMed ID: 21980934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of allergen-specific immunotherapy on platelet secretory activity in patients with grass-pollen allergy.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Vaccine; 2006 Nov; 24(47-48):6990-3. PubMed ID: 17011086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
    Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R
    Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissection of the grass allergen-specific immune response in patients with allergies and control subjects: T-cell proliferation in patients does not correlate with specific serum IgE and skin reactivity.
    Würtzen PA; van Neerven RJ; Arnved J; Ipsen H; Sparholt SH
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):241-9. PubMed ID: 9500758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.